In 2008 the pharmacy market in Poland was worth PLN 24.1bn (€6.9bn), which represented 11.5% growth in comparison with 2007. At present, it is one of the areas of the Polish economy which boasts the
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Finalising a review of the safety and efficacy of dextropropoxyphene-containing medicines, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) concluded that their r
read more »
Add this link to...
Bury
Add to:
| Bookmarks
The European Medicines Agency is inviting comments on its draft transparency policy until 25 September 2009. Since its inauguration in 1995, the Agency has worked continuously to improve the transpar
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Scientists in the UK and Switzerland have identified a signalling pathway, PI3K (phosphoinositide 3-kinase) that shows promise as a target for treating aggressive skin cancer. Their results, based on
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Can an aspirin a day keep the doctor away? New research, part of the EU-funded BIOMED (Biomedicine and health) programme, shows it can't all the time. The researchers have discovered that although r
read more »
Add this link to...
Bury
Add to:
| Bookmarks
The fight against leukaemia and malaria - two of the world's most virulent diseases - was rewarded in two out of the four categories at the recent European Inventor of the Year awards. Swiss medicin
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Chemotherapy is now often used in combination with other treatments that have different mechanisms for attacking and killing cancer cells. One such complimentary drug may be REOLYSIN, now being develo
read more »
Add this link to...
Bury
Add to:
| Bookmarks
EU-funded scientists have developed a new, non-viral way of getting genes into a cell. The technique appears to avoid the side-effects, such as cancer, which can occur when viruses are used to smuggl
read more »
Add this link to...
Bury
Add to:
| Bookmarks
The PROTECT project (Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium) has been accepted for funding by the Innovative Medicines Initiative Joint Undertaking (IMI
read more »
Add this link to...
Bury
Add to:
| Bookmarks